These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12641517)

  • 1. The prophylactic use of a proton pump inhibitor before food and alcohol.
    O'Leary C; McCarthy J; Humphries M; Shanahan F; Quigley E
    Aliment Pharmacol Ther; 2003 Mar; 17(5):683-6. PubMed ID: 12641517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
    Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS; Rowley JL
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.
    Frazzoni M; De Micheli E; Grisendi A; Savarino V
    Aliment Pharmacol Ther; 2002 Jan; 16(1):35-9. PubMed ID: 11856076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
    Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
    Bigard MA; Genestin E
    Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does short-term treatment with proton pump inhibitors cause rebound aggravation of symptoms?
    Farup PG; Juul-Hansen PH; Rydning A
    J Clin Gastroenterol; 2001 Sep; 33(3):206-9. PubMed ID: 11500608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.
    Juul-Hansen P; Rydning A; Jacobsen CD; Hansen T
    Scand J Gastroenterol; 2001 Aug; 36(8):806-10. PubMed ID: 11495074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.
    Miner PB; McKean LA; Gibb RD; Erasala GN; Ramsey DL; McRorie JW
    Aliment Pharmacol Ther; 2010 Apr; 31(8):846-51. PubMed ID: 20146702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.
    Earnest DL; Dorsch E; Jones J; Jennings DE; Greski-Rose PA
    Am J Gastroenterol; 1998 Feb; 93(2):238-43. PubMed ID: 9468251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
    Robinson M; Sahba B; Avner D; Jhala N; Greski-Rose PA; Jennings DE
    Aliment Pharmacol Ther; 1995 Feb; 9(1):25-31. PubMed ID: 7766740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and humanistic outcomes in patients with gastroesophageal reflux disease converted from omeprazole to lansoprazole.
    Nelson WW; Vermeulen LC; Geurkink EA; Ehlert DA; Reichelderfer M
    Arch Intern Med; 2000 Sep; 160(16):2491-6. PubMed ID: 10979061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal.
    Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole.
    Johnsson F; Moum B; Vilien M; Grove O; Simren M; Thoring M
    Scand J Gastroenterol; 2002 Jun; 37(6):642-7. PubMed ID: 12126240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO; Hatlebakk JG; Castell DO
    Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists.
    Kovacs TO; Campbell D; Richter J; Haber M; Jennings DE; Rose P
    Aliment Pharmacol Ther; 1999 Jul; 13(7):959-67. PubMed ID: 10383532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A; Dattilo M
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.